Epstein Secrets

19 7.2 Winding-Up 19 7.3 Liquidating Distributions 19 ARTICLE VIII MANAGEMENT 20 8.1 Management by the General Partners 20 8.2 Number of General Partners and Term of Office 23 EFTA00585178 8.3 Successor and Additional General Partners 23 8.4 Resignation 25 8.5 Death, Dissolution, Incapacity or Bankruptcy of a

ners pursuant to this Agreement. 4.2.2 Notwithstanding any other provision of this Article IV, no Partner shall be allocated in any Fiscal Year of the Partnership any Net Loss to the extent such allocation would cause or increase a deficit balance in such Partner's Capital Account, determined after taking into account all

19 7.2 Winding-Up 19 7.3 Liquidating Distributions 19 ARTICLE VIII MANAGEMENT 20 8.1 Management by the General Partners 20 8.2 Number of General Partners and Term of Office 2223 Doelk-US114734$016.4Dock USI:97341108v8 EFTA00587531 8.3 Successor and Additional General Partners 23 8.4 Resignation 2425 8.5 Death

ners pursuant to this Agreement. 4.2.2 Notwithstanding any other provision of this Article IV, no Partner shall be allocated in any Fiscal Year of the Partnership any Net Loss to the extent such allocation would cause or increase a deficit balance in such Partner's Capital Account, determined after taking into account all

19 7.2 Winding-Up 19 7.3 Liquidating Distributions 19 ARTICLE VIII MANAGEMENT 20 8.1 Management by the General Partners 20 8.2 Number of General Partners and Term of Office 23 Dock USI:9754808v8 EFTA00587491 8.3 Successor and Additional General Partners 23 8.4 Resignation 25 8.5 Death, Dissolution, Incapacity

ners pursuant to this Agreement. 4.2.2 Notwithstanding any other provision of this Article IV, no Partner shall be allocated in any Fiscal Year of the Partnership any Net Loss to the extent such allocation would cause or increase a deficit balance in such Partner's Capital Account, determined after taking into account all